- Generic name
- Dobutamine
- Strength
- 250 mg/20 ml
- Dosage form
- Injection
- Manufactured by
- Square Pharmaceuticals PLC.
Inomin Injection
About Inomin 250 mg/20 ml Injection
Inomin is a 250 mg/20 ml injection containing dobutamine, a medicine given in hospital to support the heart when its pumping is too weak for the body's needs.
There are 2 brands of Dobutamine listed in Bangladesh.
What is Inomin 250 mg/20 ml Injection?
Inomin is an injection of dobutamine, a medicine that helps the heart pump more strongly. It is used in hospital when blood flow is not enough to meet the body's needs because the heart's output is low. Dobutamine works by stimulating certain receptors in the heart muscle, which increases the force of contraction and the amount of blood pumped. This medicine is given only under close medical supervision, with monitoring of heart rate, rhythm and blood pressure. The strength is 250 mg/20 ml, and the doctor decides the dose and how long it is given.
Uses of Inomin
Inomin is used when the heart's pumping is not sufficient to meet the body's circulatory demands, a condition called hypoperfusion. It provides inotropic support, meaning it helps the heart contract more forcefully. Doctors use it in hospital settings for patients whose cardiac output is too low. It is not a treatment for mild heart symptoms and is not used at home. The doctor decides whether this medicine is suitable and for how long.
How to use Inomin
Inomin is given as an injection by healthcare professionals, usually as a continuous infusion into a vein. The rate and duration are adjusted by the doctor based on the patient's response, using monitors for heart rate, rhythm, blood pressure and, when possible, cardiac output. Patients should not adjust the infusion themselves. The doctor decides the dose and course. The injection is for hospital use only and should not be self-administered.
Side effects of Inomin
Common side effects include an increase in heart rate and blood pressure, and some patients may have more premature ventricular beats. These effects are dose related. A sudden fall in blood pressure has occasionally been reported; reducing the dose or stopping the infusion usually brings blood pressure back quickly. Other side effects may occur. Patients should tell the healthcare team about any unusual symptoms during the infusion.
Safety and precautions
Inomin should be given only under close medical supervision, with monitoring of heart rate, rhythm, arterial blood pressure and infusion rate. It is not recommended during pregnancy unless the potential benefits outweigh the risks to the foetus. It is not known if dobutamine passes into breast milk; breastfeeding should be stopped during treatment if the mother requires it. Patients with a known allergy to dobutamine should not receive it. Always ask the doctor or pharmacist about any concerns before use.
Frequently asked questions
What does the generic name dobutamine mean?
Dobutamine is the generic name of the active ingredient. It is a type of medicine called an inotropic sympathomimetic, which means it stimulates the heart to beat more forcefully. The brand Inomin contains dobutamine as its active substance.
What is Inomin used for and what kind of medicine is it?
Inomin is used in hospital when the heart's pumping is too weak to meet the body's needs. It is an inotropic sympathomimetic that increases the strength of heart contractions. It is given only under medical supervision.
What does the dosage form and strength mean?
Inomin comes as an injection, meaning it is given by healthcare professionals into a vein. The strength is 250 mg/20 ml, which tells how much dobutamine is in each vial. The doctor decides the dose and course; do not use it without medical supervision.
Can Inomin be used at home?
No, Inomin is an injection that must be given in a hospital or clinic setting under close medical supervision. It requires monitoring of heart rate, blood pressure and heart rhythm. It is not suitable for self-administration at home. Always ask the doctor or pharmacist for advice.
Indications
Pharmacology
Dosage & Administration
The rate of administration and the duration of therapy should be adjusted according to the patient's response, The indicators are: haemodynamic parameters such as heart rate and rhythm, arterial pressure, and, whenever possible, cardiac output and measurements of ventricular filling pressures and signs of pulmonary congestion. Concentrations up to 5,000 mg/L have been administered to humans. The final volume administered should be determined by the fluid requirements of the patient. Rather than abruptly discontinuing therapy with Dobutamine Hydrochloride, it is often advisable to decrease the dosage gradually.
Rates of Infusion Based on Concentration of Dobutamine Hydrochloride. The rates of fluid infusion that are required to deliver specific dosages are a function of the concentration of Dobutamine Hydrochloride in the infusate. The following table provides a guideline of infusion rates (mL/kg/min) required for 3 frequently used concentrations of Dobutamine Hydrochloride (250, 500, and 1000 mg/L).
Interaction
There has been no overt indication of medicine interactions in clinical studies in which Dobutamine Hydrochloride was administered concurrently with other medicines, including digitalis preparations, furosemide, spironolactone, lidocaine, nitroglycerin, nitroprusside, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and paracetamol.
Contraindications
Side Effects
Hypotension: Precipitous decreases in blood pressure have occasionally been described in association with dobutamine therapy. Decreasing the dose or discontinuing the infusion typically results in rapid return of blood pressure to baseline values. In rare cases, however, intervention may be required and reversibility may not be immediate.
Reactions At Sites Of Intravenous Infusion: Phlebitis has occasionally been reported. Local inflammatory changes have been described following inadvertent infiltration. Isolated cases of cutaneous necrosis (destruction of skin tissue) have been reported.
Miscellaneous Uncommon Effects: The following adverse effects have been reported in 1% to 3% of patients: nausea, headache, anginal pain, nonspecific chest pain, palpitations, and shortness of breath. Isolated cases of thrombocytopenia have been reported.
Administration of dobutamine, like other catecholamines, can produce a mild reduction in serum potassium concentration, rarely to hypokalemic levels.
Longer-Term Safety: Infusions of up to 72 hours have revealed no adverse effects other than those seen with shorter infusions.
Pregnancy & Lactation
It is not known whether this medicine is excreted in human milk. Because many medicines are excreted in human milk, caution should be exercised when Dobutamine Hydrochloride is administered to a nursing woman. If a mother requires dobutamine treatment, breastfeeding should be discontinued for the duration of the treatment.
Precautions & Warnings
Overdose Effects
Treatment: To obtain up-to-date information about the treatment of overdose, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the Physicians' Desk Reference (PDR). In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in your patient.
The initial actions to be taken in a dobutamine hydrochloride overdose are discontinuing administration, establishing an airway, and ensuring oxygenation and ventilation. Resuscitative measures should be initiated promptly. Severe ventricular tachyarrhythmias may be successfully treated with propranolol or lidocaine. Hypertension usually responds to a reduction in dose or discontinuation of therapy.
Protect the patient's airway and support ventilation and perfusion. If needed, meticulously monitor and maintain, within acceptable limits, the patient's vital signs, blood gases, serum electrolytes, etc. If the product is ingested, unpredictable absorption may occur from the mouth and the gastrointestinal tract. Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than emisis of lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Safeguard the patient's airway when employing gastric emptying or charcoal.
Forced diuresis, peritoneal dialysis, hemodialysis, or charcoal hemoperfusion have not been established as beneficial for an overdose of dobutamine hydrochloride.
Storage Conditions
Alternative brands of Dobutamine
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.